{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T08:10:53Z","timestamp":1759133453538,"version":"3.40.5"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ejpn-journal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ejpn.2024.03.005","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T18:50:54Z","timestamp":1711651854000},"page":"31-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Mitochondrial encephalopathies and myopathies: Our tertiary center's experience"],"prefix":"10.1016","volume":"50","author":[{"given":"Can","family":"Ozlu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Souad","family":"Messahel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9322-0189","authenticated-orcid":false,"given":"Berge","family":"Minassian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1081-6428","authenticated-orcid":false,"given":"Saima","family":"Kayani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejpn.2024.03.005_bib1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/scientificamerican0757-131","article-title":"Powerhouse of the cell","volume":"197","author":"Siekevitz","year":"1957","journal-title":"Sci. Am."},{"issue":"6454","key":"10.1016\/j.ejpn.2024.03.005_bib2","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw9855","article-title":"Mitochondria-Striking a balance between host and endosymbiont","volume":"365","author":"Youle","year":"2019","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ejpn.2024.03.005_bib3","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/s42255-023-00783-1","article-title":"Multifaceted mitochondria: moving mitochondrial science beyond function and dysfunction","volume":"5","author":"Monzel","year":"2023","journal-title":"Nat. Metab."},{"issue":"7","key":"10.1016\/j.ejpn.2024.03.005_bib4","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41556-018-0133-0","article-title":"Mitochondrial dynamics in adaptive and maladaptive cellular stress responses","volume":"20","author":"Eisner","year":"2018","journal-title":"Nat. Cell Biol."},{"issue":"Pt 2","key":"10.1016\/j.ejpn.2024.03.005_bib5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/BJ20110162","article-title":"Assessing mitochondrial dysfunction in cells","volume":"435","author":"Brand","year":"2011","journal-title":"Biochem. J."},{"issue":"21","key":"10.1016\/j.ejpn.2024.03.005_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111338","article-title":"Mitochondria as a cellular hub in infection and inflammation","volume":"22","author":"Andrieux","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpn.2024.03.005_bib7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.semcdb.2019.05.022","article-title":"Mitochondria as playmakers of apoptosis, autophagy and senescence","volume":"98","author":"Abate","year":"2020","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.ejpn.2024.03.005_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2020.102336","article-title":"Role of mitochondria in liver metabolic health and diseases","volume":"94","author":"Morio","year":"2021","journal-title":"Cell Calcium"},{"issue":"20","key":"10.1016\/j.ejpn.2024.03.005_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222011253","article-title":"The role of mitochondria in acute kidney injury and chronic kidney disease and its therapeutic potential","volume":"22","author":"Zhang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ejpn.2024.03.005_bib10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s13311-012-0173-2","article-title":"Genetic counseling in mitochondrial disease","volume":"10","author":"Vento","year":"2013","journal-title":"Neurotherapeutics"},{"issue":"5806","key":"10.1016\/j.ejpn.2024.03.005_bib11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/290457a0","article-title":"Sequence and organization of the human mitochondrial genome","volume":"290","author":"Anderson","year":"1981","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.ejpn.2024.03.005_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/gim.2017.107","article-title":"Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society","volume":"19","author":"Parikh","year":"2017","journal-title":"Genet. Med."},{"issue":"3","key":"10.1016\/j.ejpn.2024.03.005_bib13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1023\/B:BOLI.0000031098.41409.55","article-title":"Mitochondrial disorders: prevalence, myths and advances","volume":"27","author":"Thorburn","year":"2004","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ejpn.2024.03.005_bib14","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000402","article-title":"Mitochondrial diseases in North America","volume":"6","author":"Barca","year":"2020","journal-title":"Neurol Genet"},{"issue":"2","key":"10.1016\/j.ejpn.2024.03.005_bib15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/ana.24551","article-title":"Leigh syndrome: one disorder, more than 75 monogenic causes","volume":"79","author":"Lake","year":"2016","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.ejpn.2024.03.005_bib16","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1007\/s11011-021-00772-x","article-title":"Clinical features, pathogenesis, and management of stroke-like episodes due to MELAS","volume":"36","author":"Tetsuka","year":"2021","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ejpn.2024.03.005_bib17","series-title":"GeneReviews\u00ae [Internet]","article-title":"Merrf","author":"Velez-Bartolomei","year":"1993"},{"issue":"8","key":"10.1016\/j.ejpn.2024.03.005_bib18","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1089\/dna.2019.5010","article-title":"Clinical phenotype and genetic features of a pair of Chinese twins with kearns-sayre syndrome","volume":"39","author":"Guo","year":"2020","journal-title":"DNA Cell Biol."},{"issue":"2","key":"10.1016\/j.ejpn.2024.03.005_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ymgme.2022.05.001","article-title":"Time to harmonize mitochondrial syndrome nomenclature and classification: a consensus from the North American Mitochondrial Disease Consortium (NAMDC)","volume":"136","author":"Emmanuele","year":"2022","journal-title":"Mol. Genet. Metabol."},{"issue":"11","key":"10.1016\/j.ejpn.2024.03.005_bib20","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.3390\/molecules27113494","article-title":"Personalized medicine in mitochondrial health and disease: molecular basis of therapeutic approaches based on nutritional supplements and their analogs","volume":"27","author":"Tragni","year":"2022","journal-title":"Molecules"},{"issue":"13\u201314","key":"10.1016\/j.ejpn.2024.03.005_bib21","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.addr.2008.05.001","article-title":"The mitochondrial cocktail: rationale for combined nutraceutical therapy in mitochondrial cytopathies","volume":"60","author":"Tarnopolsky","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.ejpn.2024.03.005_bib22","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.bbagen.2011.03.015","article-title":"MELAS: a nationwide prospective cohort study of 96 patients in Japan","volume":"1820","author":"Yatsuga","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.ejpn.2024.03.005_bib23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ana.26260","article-title":"Natural history of Leigh syndrome: a study of disease burden and progression","volume":"91","author":"Lim","year":"2022","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.ejpn.2024.03.005_bib24","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1111\/ene.15814","article-title":"Phenotyping mitochondrial DNA-related diseases in childhood: a cohort study of 150 patients","volume":"30","author":"Ardissone","year":"2023","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"10.1016\/j.ejpn.2024.03.005_bib25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2478\/bjmg-2021-0019","article-title":"Clinical experience of neurological mitochondrial diseases in children and adults: a single-center study","volume":"24","author":"Rogac","year":"2021","journal-title":"Balkan J. Med. Genet."},{"issue":"3","key":"10.1016\/j.ejpn.2024.03.005_bib26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.pediatrneurol.2012.09.014","article-title":"Alpers-Huttenlocher syndrome","volume":"48","author":"Saneto","year":"2013","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ejpn.2024.03.005_bib27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pediatrneurol.2020.03.009","article-title":"MEGDEL syndrome","volume":"110","author":"Finsterer","year":"2020","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ejpn.2024.03.005_bib28","series-title":"GeneReviews\u00ae [Internet]","article-title":"Mitochondrial DNA deletion syndromes","author":"Goldstein","year":"1993"},{"issue":"6","key":"10.1016\/j.ejpn.2024.03.005_bib29","article-title":"Mitochondrial syndromes revisited","volume":"10","author":"Orsucci","year":"2021","journal-title":"Journal of Clinical Medicine [Internet]"},{"issue":"35","key":"10.1016\/j.ejpn.2024.03.005_bib30","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.2174\/138161282035140911142118","article-title":"Mitochondrial biogenesis: pharmacological approaches","volume":"20","author":"Valero","year":"2014","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejpn.2024.03.005_bib31","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.mito.2022.05.002","article-title":"Mitochondria transfer and transplantation in human health and diseases","volume":"65","author":"Wang","year":"2022","journal-title":"Mitochondrion"},{"issue":"6","key":"10.1016\/j.ejpn.2024.03.005_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.1943","article-title":"Whole exome sequencing is an alternative method in the diagnosis of mitochondrial DNA diseases","volume":"10","author":"Sun","year":"2022","journal-title":"Mol Genet Genomic Med"},{"issue":"7","key":"10.1016\/j.ejpn.2024.03.005_bib33","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3390\/children8070532","article-title":"Epilepsy in mitochondrial diseases-current state of knowledge on aetiology and treatment","volume":"8","author":"Wes\u00f3\u0142-Kucharska","year":"2021","journal-title":"Children"},{"issue":"4","key":"10.1016\/j.ejpn.2024.03.005_bib34","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/jimd.12196","article-title":"Safety of drug use in patients with a primary mitochondrial disease: an international Delphi-based consensus","volume":"43","author":"De Vries","year":"2020","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.ejpn.2024.03.005_bib35","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/164_2016_2","article-title":"Toxicity of antiepileptic drugs to mitochondria","volume":"240","author":"Finsterer","year":"2017","journal-title":"Handb. Exp. Pharmacol."},{"issue":"21","key":"10.1016\/j.ejpn.2024.03.005_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113216","article-title":"Mitochondrial epilepsy, a challenge for neurologists","volume":"23","author":"Lopriore","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.ejpn.2024.03.005_bib37","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.3390\/biomedicines10071665","article-title":"Glutamate-induced deregulation of krebs cycle in mitochondrial encephalopathy lactic acidosis syndrome stroke-like episodes (MELAS) syndrome is alleviated by ketone body exposure","volume":"10","author":"Belal","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejpn.2024.03.005_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.782657","article-title":"Neuroprotection by the ketogenic diet: evidence and controversies","volume":"8","author":"Gough","year":"2021","journal-title":"Front. Nutr."},{"issue":"5","key":"10.1016\/j.ejpn.2024.03.005_bib39","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.celrep.2019.04.005","article-title":"Functional assessment of lipoyltransferase-1 deficiency in cells, mice, and humans","volume":"27","author":"Ni","year":"2019","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.ejpn.2024.03.005_bib40","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/ajmg.a.38654","article-title":"LIPT1 deficiency presenting as early infantile epileptic encephalopathy, Leigh disease, and secondary pyruvate dehydrogenase complex deficiency","volume":"176","author":"Stowe","year":"2018","journal-title":"Am. J. Med. Genet."},{"issue":"12","key":"10.1016\/j.ejpn.2024.03.005_bib41","first-page":"2861","article-title":"Therapeutic regimen of L-arginine for MELAS: 9-year, prospective, multicenter, clinical research","volume":"265","author":"Koga","year":"2018","journal-title":"J.\u00a0Neurol."},{"issue":"23","key":"10.1016\/j.ejpn.2024.03.005_bib42","doi-asserted-by":"crossref","first-page":"e2318","DOI":"10.1212\/WNL.0000000000200299","article-title":"l-Arginine in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes: a systematic review","volume":"98","author":"Stefanetti","year":"2022","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ejpn.2024.03.005_bib43","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s40272-020-00384-5","article-title":"Therapeutic potential of citrulline as an arginine supplement: a clinical pharmacology review","volume":"22","author":"Rashid","year":"2020","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.ejpn.2024.03.005_bib44","article-title":"Arginine and citrulline for the treatment of MELAS syndrome","volume":"5","author":"El-Hattab","year":"2017","journal-title":"J\u00a0Inborn Errors Metab Screen."},{"key":"10.1016\/j.ejpn.2024.03.005_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.682780","article-title":"Nitric oxide deficiency in mitochondrial disorders: the utility of arginine and citrulline","volume":"14","author":"Almannai","year":"2021","journal-title":"Front. Mol. Neurosci."},{"issue":"3","key":"10.1016\/j.ejpn.2024.03.005_bib46","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911589","article-title":"Metabolic effects of bezafibrate in mitochondrial disease","volume":"12","author":"Steele","year":"2020","journal-title":"EMBO Mol. Med."},{"issue":"5","key":"10.1016\/j.ejpn.2024.03.005_bib47","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.2174\/1570159X20666221012122855","article-title":"Resveratrol-mediated regulation of mitochondria biogenesis-associated pathways in neurodegenerative diseases: molecular insights and potential therapeutic applications","volume":"21","author":"Shaito","year":"2023","journal-title":"Curr. Neuropharmacol."},{"issue":"12","key":"10.1016\/j.ejpn.2024.03.005_bib48","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.220274","article-title":"Mitochondrial biology and dysfunction in secondary mitochondrial disease","volume":"12","author":"Baker","year":"2022","journal-title":"Open Biol"},{"issue":"5","key":"10.1016\/j.ejpn.2024.03.005_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165682","article-title":"Disturbance of bioenergetics and calcium homeostasis provoked by metabolites accumulating in propionic acidemia in heart mitochondria of developing rats","volume":"1866","author":"Roginski","year":"2020","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"issue":"1","key":"10.1016\/j.ejpn.2024.03.005_bib50","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20150240","article-title":"Mitochondrial dysfunction in fatty acid oxidation disorders: insights from human and animal studies","volume":"36","author":"Wajner","year":"2015","journal-title":"Biosci. Rep."},{"issue":"10","key":"10.1016\/j.ejpn.2024.03.005_bib51","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1016\/j.bbadis.2015.07.014","article-title":"Impaired enzymatic defensive activity, mitochondrial dysfunction and proteasome activation are involved in RTT cell oxidative damage","volume":"1852","author":"Cervellati","year":"2015","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.ejpn.2024.03.005_bib52","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.freeradbiomed.2020.05.014","article-title":"Proteomic profiling reveals mitochondrial alterations in Rett syndrome","volume":"155","author":"Cicaloni","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejpn.2024.03.005_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2021.108790","article-title":"Impaired mitochondrial quality control in Rett Syndrome","volume":"700","author":"Crivellari","year":"2021","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejpn.2024.03.005_bib54","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.mito.2014.02.012","article-title":"Mitochondrial dysfunction in the skeletal muscle of a mouse model of Rett syndrome (RTT): implications for the disease phenotype","volume":"15","author":"Gold","year":"2014","journal-title":"Mitochondrion"},{"key":"10.1016\/j.ejpn.2024.03.005_bib55","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jpeds.2021.09.052","article-title":"Mitochondrial DNA copy number in Rett syndrome caused by methyl-CpG-binding protein-2 variants","volume":"241","author":"Liu","year":"2022","journal-title":"J.\u00a0Pediatr."},{"issue":"5","key":"10.1016\/j.ejpn.2024.03.005_bib56","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10545-017-0048-0","article-title":"Linking mitochondrial dysfunction to neurodegeneration in lysosomal storage diseases","volume":"40","author":"Saffari","year":"2017","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ejpn.2024.03.005_bib57","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1080\/13813455.2019.1628065","article-title":"Exploring the contribution of mitochondrial dynamics to multiple acyl-CoA dehydrogenase deficiency-related phenotype","volume":"127","author":"Brand\u00e3o","year":"2021","journal-title":"Arch. Physiol. Biochem."},{"issue":"8","key":"10.1016\/j.ejpn.2024.03.005_bib58","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.neuint.2010.04.002","article-title":"Neurochemical evidence that glycine induces bioenergetical dysfunction","volume":"56","author":"Busanello","year":"2010","journal-title":"Neurochem. Int."},{"issue":"4","key":"10.1016\/j.ejpn.2024.03.005_bib59","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.braindev.2017.08.002","article-title":"Avoid mitochondrion-toxic antiepileptic drugs in glycine encephalopathy","volume":"40","author":"Finsterer","year":"2018","journal-title":"Brain Dev."},{"issue":"10","key":"10.1016\/j.ejpn.2024.03.005_bib60","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1002\/ajmg.a.61786","article-title":"Mitochondrial energetic impairment in a patient with late-onset glutaric acidemia Type 2","volume":"182","author":"Xiao","year":"2020","journal-title":"Am. J. Med. Genet."}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379824000382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379824000382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T00:32:49Z","timestamp":1726360369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379824000382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":60,"alternative-id":["S1090379824000382"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2024.03.005","relation":{},"ISSN":["1090-3798"],"issn-type":[{"type":"print","value":"1090-3798"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial encephalopathies and myopathies: Our tertiary center's experience","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2024.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}